adenosine vs ivabradine
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adenosine and ivabradine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Adenocard
Corlanor
Adenosine (Adenocard) is a medicine used to treat certain types of irregular heartbeats. It belongs to a class of drugs called antiarrhythmics.
Ivabradine (Corlanor) is a medicine that helps lower the risk of needing to go to the hospital for worsening heart failure. It works by slowing down your heart rate.
Adenosine is used to treat a very fast heart rate in the upper chambers of your heart. This condition is called supraventricular tachycardia (SVT). Adenosine helps to slow down your heart rate to a normal rhythm.
Ivabradine is used to lower the chance of hospitalization if your heart failure gets worse. It is for adults who have stable, long-term heart failure and a weak heart (left ventricular ejection fraction ≤ 35%). You must also have a resting heart rate of 70 beats per minute or higher and are either taking the highest dose of beta-blockers you can handle or cannot take beta-blockers at all.
Adenosine works by slowing down the electrical signals in your heart. This helps to interrupt the fast heart rhythm and restore a normal heartbeat. It does this by acting on specific receptors in the heart tissue.
Ivabradine works by blocking certain channels in your heart called HCN channels. These channels control your heart's natural pacemaker. By blocking these channels, ivabradine slows down your heart rate.
No common side effects listed.
- • Slow heart rate
- • High blood pressure
- • Irregular heartbeat (atrial fibrillation)
- • Seeing bright flashes of light
- Supraventricular Tachycardia 94
- Hypotension 86
- Cardiac Arrest 78
- Dyspnoea 74
- Pain 67
- Dyspnoea 460
- Hypotension 413
- Dizziness 350
- Cardiac Failure 324
- Fatigue 317
Since this medication is administered by a healthcare provider in a monitored setting, there are no specific at-home warnings.
Ivabradine can harm an unborn baby. If you are a woman who could get pregnant, use effective birth control while taking this medicine. This medicine can also cause a very slow heart rate. Your doctor will monitor your heart rate and adjust your dose as needed.
It is not known if adenosine can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if adenosine passes into breast milk, so discuss this with your doctor if you are breastfeeding.
Ivabradine can cause harm to an unborn baby. Do not take this medicine if you are pregnant or planning to become pregnant. It is not recommended to breastfeed while taking ivabradine.
How to Read This adenosine vs ivabradine Comparison
adenosine is classified in the Endogenous Nucleoside (Antiarrhythmic) drug class, while ivabradine sits within the HCN Channel Blocker class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adenosine has 399 submissions while ivabradine has 1,864. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adenosine or ivabradine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.